In 2025, Basilea Pharmaceutica AG Allschwil completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Basilea Pharmaceutica AG Allschwil has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 0a | N/A | N/A | |
Total Scope 2 | ||||
Market-Based | 19.8a | 19.8a | 18.8a | |
Location-Based | N/A | 130.7a | 121.2a | |
Total Scope 3 | N/A | 1,530a | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0a | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Basilea Pharmaceutica AG Allschwil amounted to 19.8 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Basilea Pharmaceutica AG Allschwil decreased by 84.85%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2025, the total Scope 1 emissions of Basilea Pharmaceutica AG Allschwil were 0 metric tons of CO₂ equivalent (tCO₂e).a
In 2025, Basilea Pharmaceutica AG Allschwil reported Scope 2 greenhouse gas (GHG) emissions of 19.8 tCO₂e using the market-based method.a
In 2025, Basilea Pharmaceutica AG Allschwil reported its Scope 2 emissions using the market-based method.a